Navigation Links
Helios Education Foundation invests $6.5 million
Date:1/30/2008

PHOENIX, AZ Helios Education Foundation today awarded $6.5 million to the Translational Genomics Research Institute (TGen) as part of a new partnership that extends the Helios Scholars Program at TGen for the next 25 years. The program helps cultivate new scientific and technical talent across the state of Arizona.

"Helios Education Foundations commitment to develop a long term partnership with TGen for student training is an incredible boost for Arizonas future in the biosciences," Arizona Governor Janet Napolitano said. "Arizona is poised to become a world leader in cutting-edge medical education and health care, but only if we provide the necessary training and mentorship. These types of public-private partnerships hold the key to what must be the central goal of an Arizona education: giving our students the skills they need to succeed in the high-tech, high-knowledge world of the 21st century."

The Helios Scholars Program at TGen is an annual summer internship program for 45 high school, undergraduate and graduate students in Arizona. Interns receive a stipend, are paired with a TGen scientist/mentor and are actively engaged in research projects in disorders as diverse as cancer, diabetes, autism and Alzheimers disease. The eight-week program supports students from all backgrounds in their efforts to develop foundational skills as they pursue careers in science or medical-related fields.

Creating opportunities in education that have math and science at their core is very important to Helios Education Foundation, said the Foundations Chairman Vince Roig. We are excited to invest $6.5 million in this innovative and unique program at TGen because it opens new doors into the world of the biosciences for Arizona students. Were even more excited to be investing in a long-term partnership that will impact the future growth and development of the sciences in Arizona.

Helios Education Foundation provided funding for TGens 2007
'/>"/>

Contact: Amy Erickson
aerickson@tgen.org
602-343-8522
The Translational Genomics Research Institute
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Graduate Education in Physics: Which Way Forward?
2. Evolution education is a must says coalition of scientific and teaching organizations
3. Leading experts cite poor health and nutrition as major barrier to education in developing world
4. Stevens wins Excellence in Technology Education Award
5. Harold Mooney and Peter Raven, winners of the BBVA Foundation Award for Conservation Biology
6. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 17 top young investigators
7. CONRAD receives $28.5M Gates Foundation grant for HIV prevention research
8. Galapagos and Cystic Fibrosis Foundation Therapeutics announce drug discovery collaboration
9. Life-saving clean water project secures $13M from Bill & Melinda Gates Foundation
10. Arizona State University launches biofuel initiative with BP and Science Foundation Arizona
11. Simons Foundation awards Emory scientists $3M for autism gene research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/8/2014)... OhioThe future health of the world,s coral reefs and ... on the ability of one tiny symbiotic sea creature ... of algae it cooperates with. , In the first ... University discovered that coralstiny reef-forming animals that live symbiotically ... of heat stress, called "bleaching," when they keep large ...
(Date:7/8/2014)... Think of your next exercise workout as a "fun run" or ... of it as exercise or as a workout and you,ll later ... findings from the Cornell Food and Brand Lab study involved two ... a small lake and were either told it was going to ... the first study, 56 adults completed their walk and were then ...
(Date:7/8/2014)... NY, July 8, 2014Novel oligonucleotide-based drugs in development ... diseases. A group of industry and regulatory scientists ... recommendations for evaluating the pharmacological safety of oligonucleotide ... Acid Therapeutics , a peer-reviewed journal from Mary ... on the Nucleic Acid Therapeutics ...
Breaking Biology News(10 mins):For corals adapting to climate change, it's survival of the fattest -- and most flexible 2For corals adapting to climate change, it's survival of the fattest -- and most flexible 3For corals adapting to climate change, it's survival of the fattest -- and most flexible 4
... issue of G&D report on the discovery of ... The studies from Drs. Alexander Stark and Manolis ... Lai (MSKCC) and colleagues, both reveal that antisense ... the novel miRNA precursor mir-iab-8, which is processed ...
... doctors treating life-threatening emergencies such as allergy attacks may give ... Adrenaline is stored in salt water in glass ampoules ... The amount of adrenaline contained in the ampoule is usually ... per 1 mL of salt water) and a ratio (1 ...
... team at Weill Cornell Medical College in New York City ... production of an immune system cytokine called interleukin-10 (IL-10). ... in a biochemical pathway that,s long been tied to disorders ... AIDS. "IL-10 production has to be kept in a ...
Cached Biology News:Doctors may be giving the wrong dosage of adrenaline in an emergency because of labelling 22 genes are important key to regulating immune response 22 genes are important key to regulating immune response 3
(Date:1/15/2014)... (PRWEB) January 15, 2014 2013 was ... Scottsdale’s Brain State Technologies®. They saw continued independent research ... Center who were awarded a $1 million grant from ... in “Brain and Behavior” a peer reviewed journal, Amy ...
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that ... leading Russian pharmaceutical company, to develop and commercialize nemonoxacin ... , Turkey and other ... novel antibiotic for the treatment of bacterial infections including ...
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company developing ... simulated embryonic conditions, today announced that they have entered ... for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent cell ... an amendment to the existing license between Histogen and ...
(Date:1/14/2014)... New York, NY (PRWEB) January 14, 2014 ... coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua is an ... products to serve the wound care market. , Free ... Alliqua was restructured with a seasoned management team and ...
Breaking Biology Technology:Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... at the University of Central Florida have developed a ... more sensitive tool to detect pathogens associated with inflammatory ... nanoparticle-based technique also may be used for detection of ... they hide deep in human tissue and are able ...
... 2012 Genesis Biopharma, Inc. (OTCBB: GNBP), a biotechnology company ... offer shares of its common stock and warrants to purchase ... The offering is subject to market and other conditions, and ... the offering may be completed, or as to the actual ...
... wholly owned subsidiary of British company Innovative Carbon Limited today ... 10th April to 13th. , Graphene, a sheet of carbon ... wonder material. First isolated at Manchester University in 2004, ... race has been on to produce it commercially. To ...
Cached Biology Technology:UCF scientists use nanotechnology to hunt for hidden pathogens 2Genesis Biopharma Announces Proposed Public Offering of Common Stock and Warrants 2Genesis Biopharma Announces Proposed Public Offering of Common Stock and Warrants 3UK company to demonstrate their commercially effective graphene production process 2